News Releases
- Anti-CD20 Monoclonal Antibody Rituxan® Approved for Treatment of Chronic Idiopathic Thrombocytopenic Purpura in Children
- Verastem Oncology’s Announcement Regarding Avutometinib (Completion of Rolling NDA Submission to the FDA for Avutometinib plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer)
- Chugai Files for Additional Indication of Tecentriq for the Treatment of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type, a Rare Disease
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary